State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF

SPDR SERIES TRUST · 1 share class

U.S. equity index ETF
One fund, 1 share class:SLYG
$5.20B NAV
349 positions · as of 2026-06-30 · filed 2026-08-28

Fund classification

Classified from what the fund holds · as of 2026 Q2

State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF is a U.S. equity index ETF that tracks the S&P SmallCap 600 Growth Index. 35% of SLYG’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 95% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Index (passive)
Fund type
ETF

Fund profile

As filed in the prospectus · 2025 Q4

The State Street SPDR S&P 600 Small Cap Growth ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index that tracks the performance of small capitalization exchange traded U.S. equity securities exhibiting growth characteristics.

Strategy · summarised

The fund tracks the S&P SmallCap 600 Growth Index, which selects small-cap U.S. stocks (market capitalizations between $1.2 billion and $8 billion) exhibiting the strongest growth characteristics based on sales growth, earnings momentum, and price-to-earnings changes. The fund employs a sampling strategy, purchasing a subset of index securities chosen to replicate the index's risk and return profile rather than holding all constituents. Because the fund samples the index rather than holding it in full, its returns may diverge from the index.

Expenses
0.15%one share class
Share classExpense ratio
SLYG0.15%

Portfolio turnover 50.00% · as of 2025 Q4

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

102.50%
of net assets
Stocks99.90%
Cash & short-term2.60%

Derivatives are shown at market value, not notional exposure.

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
Industrials20.8%
Health Care15.6%
Information Technology15.0%
Financials14.3%
10 smaller34.3%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Portfolio growth profile

How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2

Revenue growth
35%of stock holdings in top-quartile growers
covering 95% of the fund’s equity

Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 23 new16 exited

Largest new: LQDA, ALHC, DAVE, RSI, ATMU, RELY, BFAM, NHI

Largest exited: VIAV, SANM, DOCN, SMTC, Apellis Pharmaceuticals Inc, Air Lease Corp, Sealed Air Corp, CSG Systems International Inc

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+34.60%
3-year
+56.26%
5-year
+30.29%
Volatility
14.74%
Worst 3-yr fall
-18.56%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
State Street Global AdvisorsGVMXX2.60%$135.06M
FormFactor IncFORM1.37%$71.04M
Viasat IncVSAT1.34%$69.48M
Argan IncAGX1.22%$63.53M
BrightSpring Health Services IncBTSG1.21%$62.84M
Krystal Biotech IncKRYS1.07%$55.55M
ESCO Technologies IncESE0.99%$51.66M
Alkermes PLC0.95%$49.61M
Everus Construction Group IncECG0.93%$48.24M
StoneX Group IncSNEX0.92%$47.62M
Showing 10 of 349Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 12.60% of net assets, top 25 25.08%, across 348 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free